Early-stage biotech focus Target Humboldt Fund for partnerships with its portfolio and leverage their appetite for pioneering engineering, physical sciences and life sciences to identify early-stage biotech startups with scalable value propositions.

Sustainability focus Position offerings around sustainable biotech applications such as chemicals, materials, foods, and medicines to align with Humboldt Fund’s mission to disrupt conventions and solve global issues.

Strategic co-investment Propose co-investment or syndication opportunities with Leaps by Bayer, 8VC, Felicis Ventures and similar impact/VC partners to enhance credibility and access to capital for portfolio companies.

Post-Series A readiness Highlight services for growth-stage readiness, including GMP/compliance guidance, manufacturing scale planning, and regulatory strategy to support companies progressing toward Series A milestones.

Tech-enabled outreach Utilize Humboldt Fund’s tech stack familiarity (Google Cloud, Analytics, WordPress) to offer data-driven market insights, performance dashboards, and transparent reporting to attract and retain investment interest from the fund.